Literature DB >> 31809400

Development and testing of a module to promote generic oral contraceptive prescribing among nurse practitioners.

Mark Chee1, Gena Lenti1, Jeanne Farnan1,2, Michelle Cook3, Arlene Weissman4, September Wallingford5, Christopher Moriates5,6, Neel Shah5,7, Shalini Lynch8, Marilyn Stebbins8, Samantha Ngooi2, Allison Norenberg2, Steven Millard1, Anita Samarth9, James X Zhang2, David O Meltzer2, Chris Tracy3, Vineet M Arora1,2,5.   

Abstract

Although generic oral contraceptives (OCPs) can improve adherence and reduce health care expenditures, use of generic OCPs remains low, and the factors that affect generic prescribing are not well understood. We aimed to understand the barriers and facilitators of generic OCP prescribing and potential solutions to increase generic OCP prescribing, as well as pilot an educational module to address clinician misconceptions about generic OCPs. We developed focus group scripts using the 4D model of appreciative inquiry. A total of four focus groups occurred, two at the American Association of Nurse Practitioners (AANP) national conference and two at the American College of Physicians (ACP) Internal Medicine meeting. Focus group transcripts were analyzed using a constant comparative method with no a priori hypothesis to generate emerging and reoccurring themes. Findings from these focus groups were used to develop an educational module promoting generic OCP prescribing. Participants were recruited from the AANP Network for Research and the ACP Research Panel. This study demonstrates that health system factors, workflow factors, clinician factors, and patient factors were the main barriers to and facilitators of generic OCP prescribing. Nurse practitioners were responsive to an educational module and reported increased willingness to discuss and prescribe generic OCPs after completing the module. Interventions to increase generic OCP prescribing must address clinician and patient factors within the context of workflow and larger health system factors.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31809400      PMCID: PMC7833310          DOI: 10.1097/JXX.0000000000000349

Source DB:  PubMed          Journal:  J Am Assoc Nurse Pract        ISSN: 2327-6886            Impact factor:   1.495


  12 in total

1.  Physician perceptions about generic drugs.

Authors:  William H Shrank; Joshua N Liberman; Michael A Fischer; Charmaine Girdish; Troyen A Brennan; Niteesh K Choudhry
Journal:  Ann Pharmacother       Date:  2011-01-04       Impact factor: 3.154

2.  Types of combined oral contraceptives used by US women.

Authors:  Kelli Stidham Hall; James Trussell
Journal:  Contraception       Date:  2012-07-06       Impact factor: 3.375

3.  Grounded theory in medical education research: AMEE Guide No. 70.

Authors:  Christopher J Watling; Lorelei Lingard
Journal:  Med Teach       Date:  2012-08-22       Impact factor: 3.650

4.  Standards for reporting qualitative research: a synthesis of recommendations.

Authors:  Bridget C O'Brien; Ilene B Harris; Thomas J Beckman; Darcy A Reed; David A Cook
Journal:  Acad Med       Date:  2014-09       Impact factor: 6.893

5.  Prevalence and Predictors of Generic Drug Skepticism Among Physicians: Results of a National Survey.

Authors:  Aaron S Kesselheim; Joshua J Gagne; Wesley Eddings; Jessica M Franklin; Kathryn M Ross; Lisa A Fulchino; Eric G Campbell
Journal:  JAMA Intern Med       Date:  2016-06-01       Impact factor: 21.873

6.  Generic Substitution Rates of Oral Contraceptives and Associated Out-of-Pocket Cost Savings Between January 2010 and December 2014.

Authors:  Mark Chee; James X Zhang; Samantha Ngooi; Christopher Moriates; Neel Shah; Vineet M Arora
Journal:  JAMA Intern Med       Date:  2018-04-01       Impact factor: 21.873

7.  Contraceptive methods women have ever used: United States, 1982-2010.

Authors:  Kimberly Daniels; William D Mosher
Journal:  Natl Health Stat Report       Date:  2013-02-14

8.  Potential savings from substituting generic drugs for brand-name drugs: medical expenditure panel survey, 1997-2000.

Authors:  Jennifer S Haas; Kathryn A Phillips; Eric P Gerstenberger; Andrew C Seger
Journal:  Ann Intern Med       Date:  2005-06-07       Impact factor: 25.391

9.  Generic substitution in the treatment of epilepsy: patient and physician perceptions.

Authors:  Michel J Berg; Robert A Gross; Lisa S Haskins; Wendy M Zingaro; Kenneth J Tomaszewski
Journal:  Epilepsy Behav       Date:  2008-09-10       Impact factor: 2.937

10.  Physician and pharmacist perceptions of generic medicines: what they think and how they differ.

Authors:  Suzanne Dunne; Bill Shannon; Ailish Hannigan; Colum Dunne; Walter Cullen
Journal:  Health Policy       Date:  2014-03-26       Impact factor: 2.980

View more
  1 in total

1.  Decreasing utilization and increasing prices of brand-name oral contraceptive pills: Implications to societal costs and market competition.

Authors:  James X Zhang
Journal:  PLoS One       Date:  2020-06-11       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.